289 related articles for article (PubMed ID: 11168639)
1. Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens.
Kovarik J; Bozzotti P; Tougne C; Davis HL; Lambert PH; Krieg AM; Siegrist CA
Immunology; 2001 Jan; 102(1):67-76. PubMed ID: 11168639
[TBL] [Abstract][Full Text] [Related]
2. CpG oligodeoxynucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymus-independent stimuli anti-IgM and TNP-Ficoll.
Chelvarajan RL; Raithatha R; Venkataraman C; Kaul R; Han SS; Robertson DA; Bondada S
Eur J Immunol; 1999 Sep; 29(9):2808-18. PubMed ID: 10508255
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
[TBL] [Abstract][Full Text] [Related]
4. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
Sen G; Chen Q; Snapper CM
Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes.
Li WM; Bally MB; Schutze-Redelmeier MP
Vaccine; 2001 Oct; 20(1-2):148-57. PubMed ID: 11567759
[TBL] [Abstract][Full Text] [Related]
6. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
Buchanan RM; Arulanandam BP; Metzger DW
J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
[TBL] [Abstract][Full Text] [Related]
7. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
8. T cell regulation of immunoglobulin class expression in the B cell response to TNP-Ficoll: characterization of the T cell responsible for preferential enhancement of the IgG2a response.
Mongini PK; Longo DL; Paul WE
J Immunol; 1984 Apr; 132(4):1647-53. PubMed ID: 6230389
[TBL] [Abstract][Full Text] [Related]
9. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
[TBL] [Abstract][Full Text] [Related]
10. Neonatal murine B lymphocytes respond to polysaccharide antigens in the presence of IL-1 and IL-6.
Chelvarajan RL; Gilbert NL; Bondada S
J Immunol; 1998 Oct; 161(7):3315-24. PubMed ID: 9759847
[TBL] [Abstract][Full Text] [Related]
11. CpG DNA is an effective oral adjuvant to protein antigens in mice.
McCluskie MJ; Weeratna RD; Krieg AM; Davis HL
Vaccine; 2000 Nov; 19(7-8):950-7. PubMed ID: 11115721
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.
Diwan M; Tafaghodi M; Samuel J
J Control Release; 2002 Dec; 85(1-3):247-62. PubMed ID: 12480329
[TBL] [Abstract][Full Text] [Related]
13. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
[TBL] [Abstract][Full Text] [Related]
14. T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch.
Mongini PK; Paul WE; Metcalf ES
J Exp Med; 1982 Mar; 155(3):884-902. PubMed ID: 6977611
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to T-dependent and T-independent antigens during visceral leishmaniasis in mice: evidence for altered T-cell regulation of immune responses to non-parasite antigens.
Reed SG; Roters SB; Inverso JA; Jones TC; Goidl EA
Cell Immunol; 1985 Nov; 96(1):12-25. PubMed ID: 2424616
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody.
Chen W; Yu Y; Shao C; Zhang M; Wang W; Zhang L; Cao X
Immunol Lett; 2001 May; 77(1):17-23. PubMed ID: 11348665
[TBL] [Abstract][Full Text] [Related]
17. Antibody formation in mouse bone marrow during secondary type responses to various thymus-independent antigens.
Koch G; Lok BD; Benner R
Immunobiology; 1982 Dec; 163(5):484-96. PubMed ID: 6984419
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulation in the rat: ontogeny of B cell responses to types 1, 2, and T-dependent antigens.
Kimura S; Eldridge JH; Michalek SM; Morisaki I; Hamada S; McGhee JR
J Immunol; 1985 May; 134(5):2839-46. PubMed ID: 2580000
[TBL] [Abstract][Full Text] [Related]
19. Differential responses of B cells from the spleen and lymph node to TNP-Ficoll.
Goud SN; Muthusamy N; Subbarao B
J Immunol; 1988 May; 140(9):2925-30. PubMed ID: 3129503
[TBL] [Abstract][Full Text] [Related]
20. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.
Bernard MP; Phipps RP
Clin Immunol; 2007 Nov; 125(2):138-48. PubMed ID: 17728187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
